These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35267199)

  • 1. The Virtual Inpatient Diabetes Management Service: COVID-19 brings the future to inpatient diabetes management.
    Cheung NW; Hor A; Hng TM
    Med J Aust; 2022 Apr; 216(6):321-322. PubMed ID: 35267199
    [No Abstract]   [Full Text] [Related]  

  • 2. Inpatient Diabetes Management During the COVID-19 Crisis: Experiences From Two Community Hospitals.
    Shelton C; Demidowich AP; Zilbermint M
    J Diabetes Sci Technol; 2020 Jul; 14(4):780-782. PubMed ID: 32486900
    [No Abstract]   [Full Text] [Related]  

  • 3. Inpatient Transition to Virtual Care During COVID-19 Pandemic.
    Jones MS; Goley AL; Alexander BE; Keller SB; Caldwell MM; Buse JB
    Diabetes Technol Ther; 2020 Jun; 22(6):444-448. PubMed ID: 32396395
    [No Abstract]   [Full Text] [Related]  

  • 4. The Use of eHealth for the Care of Patients With Diabetes in Connection to the COVID-19 Pandemic.
    Jendle J
    J Diabetes Sci Technol; 2020 Jul; 14(4):739-740. PubMed ID: 32375494
    [No Abstract]   [Full Text] [Related]  

  • 5. Inpatient diabetes care during the COVID-19 pandemic: A Diabetes UK rapid review of healthcare professionals' experiences using semi-structured interviews.
    Burr O; Berry A; Joule N; Rayman G
    Diabet Med; 2021 Jan; 38(1):e14442. PubMed ID: 33112438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit.
    Zhang JY; Shang T; Ahn D; Chen K; Coté G; Espinoza J; Mendez CE; Spanakis EK; Thompson B; Wallia A; Wisk LE; Kerr D; Klonoff DC
    J Diabetes Sci Technol; 2021 Mar; 15(2):478-514. PubMed ID: 33476193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and diabetes: What have we learned so far?
    Taher N; Huda MS; Chowdhury TA
    Clin Med (Lond); 2020 Jul; 20(4):e87-e90. PubMed ID: 32628128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in Telemedicine Use for Subspecialty Diabetes Care During COVID-19 Shelter-In-Place Orders.
    Haynes SC; Kompala T; Neinstein A; Rosenthal J; Crossen S
    J Diabetes Sci Technol; 2021 Sep; 15(5):986-992. PubMed ID: 33719622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting.
    Fleming N; Sacks LJ; Pham CT; Neoh SL; Ekinci EI
    Diabet Med; 2021 Mar; 38(3):e14509. PubMed ID: 33377213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes Mellitus and COVID-19: Review Article.
    Nassar M; Daoud A; Nso N; Medina L; Ghernautan V; Bhangoo H; Nyein A; Mohamed M; Alqassieh A; Soliman K; Alfishawy M; Sachmechi I; Misra A
    Diabetes Metab Syndr; 2021; 15(6):102268. PubMed ID: 34562865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of COVID-19 on telemedicine in diabetes management: the Belgian experience].
    Radermecker RP
    Rev Med Suisse; 2022 Aug; 18(792):1552-1555. PubMed ID: 36004655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inpatient Diabetes and Hyperglycemia Management Protocol in the COVID-19 Era.
    Aljehani FA; Funke K; Hermayer KL
    Am J Med Sci; 2020 Oct; 360(4):423-426. PubMed ID: 32736827
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa.
    Giorgino F; Bhana S; Czupryniak L; Dagdelen S; Galstyan GR; Janež A; Lalić N; Nouri N; Rahelić D; Stoian AP; Raz I
    Diabetes Res Clin Pract; 2021 Feb; 172():108617. PubMed ID: 33310175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes Care During COVID-19 Pandemic in Singapore Using a Telehealth Strategy.
    Lian X; Dalan R; Seow CJ; Liew H; Jong M; Chew D; Lim B; Lin A; Goh E; Goh C; Othman NB; Tan L; Boehm BO
    Horm Metab Res; 2021 Mar; 53(3):191-196. PubMed ID: 33530117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new virtual inpatient dermatology electronic referral service: a timely solution in the COVID-19 pandemic and beyond?
    Lowe A; Pararajasingam A; Ali FM; Dawood S; Lowe CD; Stone NM
    J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):e430-e432. PubMed ID: 33780552
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 and Diabetes: Could Diabetes Technology Research Help Pave the Way for Remote Healthcare?
    Fuchs J; Hovorka R
    J Diabetes Sci Technol; 2020 Jul; 14(4):735-736. PubMed ID: 32475169
    [No Abstract]   [Full Text] [Related]  

  • 17. Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic.
    Ghosh A; Dutta K; Tyagi K; Gupta R; Misra A
    Diabetes Metab Syndr; 2020; 14(4):577-578. PubMed ID: 32416526
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of COVID-19 Pandemic on Pediatric Diabetes Mellitus.
    Shin CH
    J Korean Med Sci; 2022 Jun; 37(22):e186. PubMed ID: 35668690
    [No Abstract]   [Full Text] [Related]  

  • 19. Initial Results and Patient Survey of Virtual Inpatient Ophthalmology Consultations During the COVID-19 Pandemic.
    Kalra G; Commiskey PW; Schempf T; Williams AM; Bowers EMR; Waxman EL; Fu R
    Semin Ophthalmol; 2021 Oct; 36(7):461-468. PubMed ID: 33641597
    [No Abstract]   [Full Text] [Related]  

  • 20. Telemedicine During the COVID-19 Crisis and Beyond.
    Blevins T; Ozer K
    Tex Med; 2020 Jul; 116(7):4-5. PubMed ID: 32872703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.